Dr. Amy Hennessy is a board-certified glaucoma-trained ophthalmologist. She specializes in the medical, laser and surgical treatments for glaucoma. She also performs cataract surgery and has access to the latest implantable devices for the minimally invasive treatment of glaucoma.
A native of Rhode Island, Dr. Hennessy graduated from Providence College, where she was a member of the Pre-Medical and Mathematics societies. She was a Student Athletic Trainer, and also volunteered for medical missions to Guatemala, where she was able to solidify her interest in medicine. She went on to attend medical school at Brown University in Providence, RI, and when she realized she needed glasses, her love for ophthalmology was ignited. She received a Masters in Public Health from Johns Hopkins University in Baltimore, Maryland, where she received a Capstone Award for Outstanding Achievement for her research on ocular trauma in rural Nepal.
Dr. Hennessy completed her Ophthalmology residency at Virginia Commonwealth University in Richmond, Virginia and her glaucoma fellowship with Dr Alan Robin in Baltimore, Maryland. Dr Hennessy has published many peer-reviewed articles and has presented at local and national conferences on her research, which centered on glaucoma patients’ compliance with eyedrop instillation. She is a reviewer for many ophthalmology journals. She is a member of the American Academy of Ophthalmology and the American Glaucoma Society, as well as the state society.
After practicing several years in Maryland and California, Dr. Hennessy and her family were happy to return to New England, where they enjoy the weather and the sports teams! She enjoys traveling, exploring new restaurants, going on outdoor adventures with her family, and riding her Peloton bike.
Dr. Hennessy is affiliated with the Elliot Hospital system, the Veterans Hospital in Manchester, Bedford Ambulatory Surgery Center, and Nashua Ambulatory Surgery Center.
Dr. Hennessy has also been chosen by her peers as one of New Hampshire Magazine’s “Top Doctors” for 2022 and 2023 in the field Ophthalmology.